The error: "Rybelsus is an oral form of semaglutide, the same medication in Ozempic and Wegovy, proven to cause significant weight loss." Why it's wrong: Rybelsus contains semaglutide, but at a dose and formulation NOT proven effective for obesity treatment
Popova T, Hebert L, Jacquemin V, et al
Here, we review the role of GLP-1 and the actions of associated therapies on glucose metabolism, the gutrenal axis, classical renal risk factors, and renal end points in randomized controlled trials of GLP-1 receptor agonists and DPP-4 inhibitors in patients with T2DM
Suspected adverse reactions to either preparation should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
What happens if there isnt anyone available for the delivery